These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of hyperlipidemia in diabetes mellitus. Dunn FL Endocrinol Metab Clin North Am; 1992 Jun; 21(2):395-414. PubMed ID: 1612072 [TBL] [Abstract][Full Text] [Related]
4. Management of hypercholesterolaemia in the patient with diabetes. Packard C; Olsson AG Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606 [TBL] [Abstract][Full Text] [Related]
5. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2]. Wolffenbuttel BH; Huijberts MS Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of hyperlipoproteinemia in patients with diabetes mellitus]. Dammann HG; Dreyer M; Wernecke J; Lankers H; Müller P; Simon B Fortschr Med; 1990 May; 108(15):305-8. PubMed ID: 2204598 [TBL] [Abstract][Full Text] [Related]
7. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
9. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients. Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995 [TBL] [Abstract][Full Text] [Related]
11. [Lipids--diagnosis and therapy in type 2 diabetes]. Wascher TC Acta Med Austriaca; 2004; 31(5):168-9. PubMed ID: 15747990 [TBL] [Abstract][Full Text] [Related]
12. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. Pastromas S; Terzi AB; Tousoulis D; Koulouris S Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia. Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378 [TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia. Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607 [TBL] [Abstract][Full Text] [Related]
16. Drug therapy for hyperlipidemia. Franklin FA; Margolis S Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855 [No Abstract] [Full Text] [Related]
17. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?]. Broedl UC; Lehrke M; Parhofer KG MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054 [No Abstract] [Full Text] [Related]
18. [Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus]. Panchenko VM; Ershov AA; Isaev VA; ZImovchenko GS; Chernova GI Klin Med (Mosk); 2001; 79(6):47-9. PubMed ID: 11521381 [TBL] [Abstract][Full Text] [Related]
19. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data. Lewis GF Can J Cardiol; 1995 May; 11 Suppl C():24C-28C. PubMed ID: 7750045 [TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia in type 2 diabetes. Krauss RM; Siri PW Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]